Harvard Bioscience
HBIO
HBIO
80 hedge funds and large institutions have $87.3M invested in Harvard Bioscience in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
82% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 17
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
80
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.35M | |
| 2 | +$507K | |
| 3 | +$415K | |
| 4 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$379K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$347K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$1.15M | |
| 3 | -$1.02M | |
| 4 |
Renaissance Technologies
New York
|
-$572K |
| 5 |
AIP
ARS Investment Partners
New York
|
-$519K |